Research Alliance IV (RACD)

Searches for a business combination, with intended targets in drug development and commercialization, diagnostics, and healthcare technology and services. The sponsor is affiliated with RA Capital Management, and the process relies on its scientific diligence, investing network, and company-building resources to source and assess candidates. Although organized in the Cayman Islands, the executive office is in New York, and the search has no formal geographic restriction.

Does not operate a business, sell products, or generate operating revenue before a combination. Trust cash, new equity, debt, or a mix may finance the transaction, while shareholders may redeem their shares around it. Competition comes from other SPACs, private equity, public companies, and strategic buyers, and completing a deal depends on a selected target, financing, shareholder redemptions, sponsor consent, and a deadline to complete the combination.